✦ LIBER ✦

Cost Effectiveness of Aspirin, Clopidogrel, or Both for Secondary Prevention of Coronary Heart Disease

✍ Scribed by Gaspoz, Jean-Michel; Coxson, Pamela G.; Goldman, Paula A.; Williams, Lawrence W.; Kuntz, Karen M.; Hunink, M.G. Myriam; Goldman, Lee

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

802-6 The Cost-Effectiveness of Pravasta

✍ Ashraf, Talat; Hay, Joel W.; Crouse, John R.; Davidson, Michael H.; Furberg, Cur 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 139 KB

Cost-Effectiveness of Clopidogrel plus A

✍ Jersey Chen; Deepak L. Bhatt; Elizabeth Schneider Dunn; Chunxue Shi; J. Jaime Ca 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

Randomized trial of aspirin, sibrafiban,

📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 38 KB

PCV18: COST-EFFECTIVENESS OF PREVENTION

✍ M Geitona; J Kyriopoulos; C Geitonas; A Papademetriou; V Nikolaou 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Cost-Effective Prevention of Coronary He

✍ Dominique Ashen 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 256 KB

Clopidogrel versus aspirin for secondary

✍ M.D. Schleinitz; J.P. Weiss; D.K. Owens 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 39 KB